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Abstract. Radiotherapy treatment plans using dynamic couch rotation during
volumetric modulated arc therapy (DCR-VMAT) reduce the dose to organs at risk
(OARs) compared to coplanar VMAT, while maintaining the dose to the planning
target volume (PTV). This paper seeks to validate this finding with measurements.
DCR-VMAT treatment plans were produced for five patients with primary brain
tumours and delivered using a commercial linear accelerator (linac). Dosimetric
accuracy was assessed using point dose and radiochromic film measurements. Linac-
recorded mechanical errors were assessed by extracting deviations from log files
for multi-leaf collimator (MLC), couch, and gantry positions every 20 ms. Dose
distributions, reconstructed from every fifth log file sample, were calculated and used
to determine deviations from the treatment plans. Median (range) treatment delivery
times were 125 s (123–133 s) for DCR-VMAT, compared to 78 s (64–130 s) for coplanar
VMAT. Absolute point doses were 0.8% (0.6–1.7%) higher than prediction. For coronal
and sagittal films, respectively, 99.2% (96.7–100%) and 98.1% (92.9–99.0%) of pixels
above a 20% low dose threshold reported gamma <1 for 3% and 3 mm criteria. Log file
analysis showed similar gantry rotation root-mean-square error (RMSE) for VMAT and
DCR-VMAT. Couch rotation RMSE for DCR-VMAT was 0.091◦ (0.086–0.102◦). For
delivered dose reconstructions, 100% of pixels above a 5% low dose threshold reported
gamma <1 for 2% and 2 mm criteria in all cases. DCR-VMAT, for the primary brain
tumour cases studied, can be delivered accurately using a commercial linac.
Keywords: VMAT, Non-coplanar, Trajectory, Verification, Log file, Dose reconstruction
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1. Introduction
Radiotherapy treatment plans that use dynamic couch rotation during volumetric
modulated arc therapy (DCR-VMAT) improve organ at risk (OAR) sparing over
coplanar VMAT, while maintaining planning target volume (PTV) dose coverage
(Podgorsak et al 1988, Krayenbuehl et al 2006, Shaitelman et al 2011, Yang et al
2011, Popescu et al 2013, Smyth et al 2013, Fahimian et al 2013, MacDonald and
Thomas 2015, Wild et al 2015, Papp et al 2015, Liang et al 2015, Smyth et al 2016,
Wilson et al 2017, Langhans et al 2018, Lyu et al 2018, Dong et al 2018, Fix et al
2018, Smyth et al 2019). Single-arc DCR-VMAT using optimized trajectories has been
shown to reduce the contralateral hippocampus, temporal lobe, and cochlea mean dose
by 30%, 29%, and 14%, respectively, for a cohort of fifteen primary brain tumour cases
(Smyth et al 2016). However, to fully realize this modelled OAR sparing, DCR-VMAT
plans must be delivered accurately. The International Commission on Radiation Units
and Measurements (ICRU) recommends that 85% of measurement points should be
within 5% or 5 mm of the planned dose (ICRU 2010), although stricter criteria of
3% and 3 mm are generally used in practice (Clark et al 2014). If delivered doses
are significantly different from prediction, this could increase the risk of side effects or
compromise tumour control. In addition, clinical adoption of DCR-VMAT would be
limited if its delivery is significantly slower than coplanar VMAT and requires patient
treatment appointments to be extended beyond their current duration.
Dosimetric accuracy and mechanical errors have been reported for some dynamic
couch rotation techniques. Fahimian et al (2013) and Liang et al (2015) investigate
the dosimetric accuracy of trajectory modulated arc therapy (TMAT), a combination
of dynamic couch rotation and fixed gantry rotation, for two accelerated partial breast
irradiation (APBI) cases. Manser et al (2018) and Fix et al (2018) report the dosimetric
accuracy of DCR-VMAT for a prostate case using a manually defined trajectory and
a head and neck case using a geometrically optimized trajectory, respectively. As well
as dosimetric accuracy, Wilson et al (2017) quantify linac-reported mechanical errors
during delivery for their mathematically-defined trajectory-based VMAT (TVMAT)
technique for four intracranial stereotactic plans from linac log files. Log files record
the machine parameters regularly during beam delivery, with the period between log
samples depending on the combination of linac manufacturer and control system version
(Pasler et al 2015).
This paper focuses on investigating the dosimetric accuracy of single-arc DCR-
VMAT plans for five primary brain tumour cases. The dosimetric effect of mechanical
errors and the static approximation of dynamic couch rotation used during treatment
plan dose calculation are investigated for the first time by reconstructing delivered dose
distributions from log files. Finally, results are benchmarked against the corresponding
coplanar VMAT plans for each of the five cases studied.
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Table 1. Diagnosis and planning target volume (PTV) details for all patient cases.
Case Diagnosis PTV volume (cm3)
1 Craniopharyngioma 5.5
2 Craniopharyngioma 31.7
3 Oligoastrocytoma 554.2
4 Astrocytoma 505.6
5 Astrocytoma 151.2
2. Materials and methods
2.1. Beam modelling
A TrueBeam (Varian Medical Systems, Sunnyvale, CA) linac was modelled in the
Pinnacle3 (v9.10, Philips Medical, Madison, WI) and in-house AutoBeam (Bedford
2009, 2013) treatment planning systems (TPS). TrueBeam is the only currently available
machine capable of delivering dynamic couch rotation treatment plans, however in
principle DCR-VMAT can be delivered on any VMAT capable C-arm linac.
Modelling was performed for a 6 MV beam within Pinnacle3 using its auto-
modelling features and the literature (Chang et al 2012, Glide-Hurst et al 2013, Philips
Medical 2013) to inform modelling parameters. Validation was performed using a 30
cm x 30 cm x 30 cm water phantom with dose calculated on a 2.0 mm x 2.0 mm x 2.0
mm grid. Absolute point doses, relative output factors, percentage depth doses, and
relative dose profiles were compared with validation measurements for jaw-defined field
sizes. Validation of modulated deliveries was performed by measuring the dosimetric
accuracy of coplanar VMAT plans for each patient case.
2.2. Treatment planning and delivery
VMAT and DCR-VMAT plans, each using a single arc, were produced for five patient
cases with primary brain tumours (Table 1). Treatment plans for the TrueBeam model
were optimized in AutoBeam (v5.5a) to receive 54 Gy in 30 fractions using the objectives
described in Table 2. During treatment plan optimization, jaws under the multi-leaf
collimator (MLC) banks were set as static and retracted to 10 cm in preparation for
TrueBeam delivery. Plans were exported to Pinnacle3 for final dose calculation using
the local clinical standard settings of a 2.5 mm x 2.5 mm x 2.5 mm dose grid resolution
and the Adaptive Convolve algorithm. Dose calculation for DCR-VMAT was performed
using multiple static control points, each with associated gantry and couch positions, as
is standard for coplanar VMAT within Pinnacle3.
For DCR-VMAT plans, patient-specific trajectories were determined using the
geometric heuristic optimization technique described previously (Smyth et al 2013,
2016). The organs at risk and their relative importance values used during treatment
plan optimization were also used for trajectory optimization (Table 2). Each DCR-
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Table 2. Optimization parameters used within AutoBeam for VMAT and DCR-
VMAT treatment planning. Organs at risk and their relative importance values were
also used for DCR-VMAT trajectory optimization. RMS = root mean square deviation.
Region of interest Objective Relative importance
PTV Minimize RMS around 54 Gy 100
Brainstem Minimize maximum dose 10
Globes Minimize maximum dose 5
Optic nerves Minimize maximum dose 5
Optic chiasm Minimize maximum dose 5
Lenses Minimize mean dose 5
Hippocampi Minimize mean dose 3
Temporal lobes Minimize mean dose 2
Cochleae Minimize mean dose 1
Brain excluding other ROIs Minimize mean dose 1
VMAT trajectory used a single gantry arc from 179◦ to 181◦, with maximum couch
and gantry rotations between adjacent control points of 2◦. No additional processing
or smoothing was performed on the trajectories prior to treatment planning or delivery.
Couch rotation speed between adjacent control points was not explicitly included in
treatment plan optimization but was determined by the linac control system at delivery.
As dynamic couch motion during beam delivery was not supported within the
clinical TrueBeam control software, plans were delivered using research and development
access with motion restrictions removed (“Developer Mode”). AutoBeam DICOM plan
files were converted to Extensible Mark-up Language (XML) format for Developer Mode
delivery (Varian Medical Systems 2013) using Veritas v2.2 (Mishra et al 2014). The steps
from trajectory optimization to plan delivery, comparisons performed, and systems used
are summarized in Figure 1.
2.3. Dosimetric accuracy
A 30 cm x 30 cm x 30 cm phantom, consisting of multiple slabs of solid water, was
used for dosimetric verification. The expected dose distribution for each treatment plan
when delivered to the verification phantom was calculated in Pinnacle3. The Adaptive
Convolve algorithm and a 2.0 mm x 2.0 mm x 2.0 mm resolution dose grid were used
for all cases.
For each plan, a position for point dose measurement was identified in a region of
homogeneous dose within the PTV. A region of interest (ROI) that approximated the
0.125 cm3 collecting volume of a Semiflex ionisation chamber (PTW, Freiburg, Germany)
was contoured, centred on the measurement position, and the mean dose to the ROI
for a single fraction delivery defined the predicted dose. Measurements were performed
using the Semiflex chamber and a Unidos electrometer (PTW, Freiburg, Germany);
three measurements were taken and averaged for each plan.
Radiochromic film measurements were performed using EBT3 (Lot number
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Figure 1. Flowchart showing the steps from plan generation to delivery (light boxes)
and the comparisons investigated in this paper (dark boxes). Dashed boxes indicate
the software or hardware in which the steps were performed.
04051602; Ashland Advanced Materials, Bridgewater, NJ). To characterize the dose to
colour value conversion for the film batch, six strips were cut from a single sheet of film
and irradiated to 25, 50, 100, 200, 400 and 800 cGy in a water-equivalent phantom, in
line with Lewis and Chan (2015) and manufacturer recommendations‡. A seventh film
strip was left unirradiated. Films were scanned using an Epson 11000XL flatbed scanner
(Epson America, Inc., Long Beach, CA) in transmission mode, with a resolution of 72
dpi. To reduce uncertainties caused by film curling, a 2 mm thick glass compression plate
was placed on top of the films during scanning (Palmer et al 2015). Films were analysed
using FilmQA Pro (v3.0, Ashland Advanced Materials, Bridgewater, NJ) software.
Coronal and sagittal planes through the PTV were measured for each VMAT and
DCR-VMAT plan. Two film strips were cut from each film sheet, one of which was
irradiated to 170 cGy, and used to scale the calibration curve for that measurement
(Lewis et al 2012). Dosimetry was analysed using the triple channel method to mitigate
uncertainties due to the film scanner and variations in film thickness (Micke et al 2011).
Film to plan registration was performed by aligning the marked film isocentre position
with the plan isocentre position, small discrepancies between marked and actual film
position were removed using the optimization option in FilmQA Pro. Comparison of
red colour channel measurements with predictions was performed using two-dimensional
gamma analysis with criteria of 3% (global dose difference normalisation) and 3 mm
(γ3G/3). Analysis with a stricter distance to agreement criterion of 1 mm (γ3G/1) was
also performed. When reporting passing rates for gamma analysis, pixels below a low
‡ Efficient Protocols for Accurate Radiochromic Film Calibration and Dosimetry
http://www.gafchromic.com/documents/Efficient%20Protocols%20for%20Calibration%20and%20Dosimetry.pdf
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dose threshold of 20% were excluded (Clark et al 2014).
2.4. Linac log file analysis
Linac log files were acquired during delivery of each treatment plan. TrueBeam log
files record the primary readout of the linac motion axes and MLC leaf positions every
20 ms during beam delivery, as well as values interpolated from the original DICOM
plan (Eckhause et al 2015). These form “delivered” and “expected” log file values,
respectively, making it possible to determine mechanical errors every 20 ms during
treatment. Expected and delivered log file values for gantry rotation, couch rotation,
and all MLC leaves were extracted using a MATLAB (v2010b, The Mathworks, Nantick,
MA) script. For each parameter the root-mean-square error (RMSE) was calculated
according to Equation 1.
RMSE =
√√√√ 1
N
N∑
1
(Dn − En)2 (1)
where N was the total number of log file samples, and D and E were the delivered and
expected log file parameter values for sample n.
To determine if RMSE values of individual MLC leaves were correlated with the
total motion of the MLC leaf, Spearman’s rank correlation coefficients were calculated
in MATLAB. This was performed for each MLC leaf bank for both VMAT and DCR-
VMAT. If the p-value associated with a correlation coefficient was less than 0.05, the
correlation was judged to be statistically significant.
2.5. Linac log file dose reconstruction
The dosimetric difference between the Pinnacle3 treatment plan and dynamic plan
delivery was determined by reconstructing a plan from each log file. VMAT and DCR-
VMAT plans were created in Pinnacle3 with control points specified by the delivered log
file values of gantry rotation, couch rotation, aperture shape, and cumulative monitor
units. To reduce the control points to a manageable number for calculation within
Pinnacle3, every fifth log file sample was used, resulting in a beam with ten control
points per second. Reconstructed plan doses were calculated on the patient CT data
using the local clinical standard settings of a 2.5 mm x 2.5 mm x 2.5 mm dose grid
resolution and the Adaptive Convolve algorithm.
Planned and delivered dose cubes were exported to CERR v5.2 (Deasy et al 2003)
for comparison using three-dimensional (3D) gamma analysis for all voxels above a 5%
low dose threshold with 2% and 2 mm acceptance criteria (γ2G/2). Dose criteria were
relative to the global maximum of the planned dose cube, which was used as the reference
distribution. Both dose calculations shared the same beam model, dose grid settings,
and dose calculation algorithm. This left two sources of error in this comparison: (1)
the number of control points used to calculate the dose, and (2) the mechanical errors
recorded in the delivered log file. Therefore, stricter gamma analysis criteria were used
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Figure 2. DCR-VMAT trajectories optimized for each patient case. The shaded
corner regions indicate forbidden areas of the solution space where collisions between
the linac gantry and patient or patient couch were likely.
for these comparisons than for the radiochromic film measurements. To identify the
main cause of any discrepancies, an additional dose distribution was reconstructed from
the expected linac log files and compared with the original treatment plan.
3. Results
3.1. Beam modelling
Absolute point dose measurements and relative output factors of jaw-defined fields used
for TrueBeam model validation were within ±1% of predictions. Pinnacle3 percentage
depth doses and profiles agreed with validation measurements to within 2% or 2 mm
(generally 1% or 1 mm). Results for the validation of modulated delivery using coplanar
VMAT plans are presented in Section 3.3 to allow direct comparison against DCR-
VMAT measurements.
3.2. Treatment planning and delivery
Optimized DCR-VMAT trajectories are shown in Figure 2. Axial, coronal, and sagittal
views of DCR-VMAT treatment plans for each case are shown in Figure 3. Dose volume
histograms for VMAT and DCR-VMAT plans are shown in Figure 4. Due to the
relatively small number of cases investigated, results are quoted as median (range)
values throughout. Monitor units were 276.3 (258.5–296.4) for DCR-VMAT compared
with 239.9 (220.9–272.7) for coplanar VMAT. Delivery times were 125 s (123–133 s)
for DCR-VMAT compared with 78 s (64–130 s) for coplanar VMAT. Monitor units,
delivery times, and numbers of control points are presented for all cases in Table 3.
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Figure 3. DCR-VMAT plan dose distributions presented on axial, coronal and sagittal
views for all cases. The planning target volume (PTV) contour is overlaid on the dose
colourwash.
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Figure 4. Dose volume histograms for each case, showing coplanar VMAT (solid line)
and DCR-VMAT (dashed line) results.
Table 3. Monitor units, delivery times, and numbers of control points for VMAT and
DCR-VMAT plans for each case.
Monitor units Delivery time (s) Control points
Case VMAT DCR-VMAT VMAT DCR-VMAT VMAT DCR-VMAT
1 272.7 296.4 64 133 180 180
2 251.5 283.5 65 128 180 180
3 220.9 258.5 126 123 180 180
4 229.2 262.6 130 123 180 180
5 239.9 276.3 78 125 180 202
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Table 4. Predicted and measured absolute point doses for coplanar VMAT and DCR-
VMAT plans.
VMAT DCR-VMAT
Dose (cGy) Difference Dose (cGy) Difference
Case Predicted Measured (%) Predicted Measured (%)
1 135.2 136.0 0.6 140.7 141.5 0.6
2 133.4 134.6 0.9 137.0 139.3 1.7
3 134.7 136.5 1.3 136.4 137.2 0.6
4 138.9 140.9 1.5 133.8 134.9 0.8
5 135.2 137.3 1.6 142.3 143.5 0.8
Table 5. Percentage of coronal and sagittal film pixels receiving a dose of at least 20%
with a gamma <1 at 3% / 3 mm and 3% / 1 mm for coplanar VMAT and DCR-VMAT
plans.
3% / 3 mm 3% / 1 mm
VMAT DCR-VMAT VMAT DCR-VMAT
Case Coronal Sagittal Coronal Sagittal Coronal Sagittal Coronal Sagittal
1 100 81.0 99.2 96.0 91.4 42.9 83.5 90.8
2 97.6 87.0 98.3 98.2 75.9 68.0 80.5 81.0
3 100 99.0 100 92.9 99.0 81.3 99.5 82.1
4 100 99.1 99.8 99.0 99.5 90.3 95.7 89.5
5 99.5 96.6 96.7 98.1 93.2 80.8 85.4 86.6
3.3. Dosimetric accuracy
Median (range) differences in absolute dose from plan prediction were 0.8% (0.6–1.7%)
for DCR-VMAT compared with 1.3% (0.6–1.6%) for VMAT. Complete results are
presented in Table 4. Linac output on the day of measurement, which remained as
a potential source of uncertainty in the point dose results, was 0.4% higher than ideal.
DCR-VMAT median gamma analysis pass rates, for doses greater than a 20%
threshold using γ3G/3, were 99.2% (range 96.7–100%) for coronal and 98.1% (92.9–99.0%)
for sagittal measurements. Coplanar VMAT gamma analysis pass rates were 100%
(97.6–100%) for coronal and 96.6% (81.0–99.1%) for sagittal measurements. Analysis
using gamma criteria of 3% and 1 mm (γ3G/1) gave results of 85.4% (80.5–99.5%) for
coronal DCR-VMAT, 86.6% (81.0–90.8%) for sagittal DCR-VMAT, 93.2% (75.9–99.5%)
for coronal VMAT, and 80.8% (42.9–90.3%) for sagittal VMAT. Complete results are
presented in Table 5. Further analysis of sagittal VMAT cases 1 and 2 using gamma
criteria of 5% and 3 mm (γ5G/3) gave results of 99.4% and 97.2%, respectively. Gamma
analysis maps (γ3G/3) and isodose comparisons for all DCR-VMAT cases are shown in
Figure 5. Dose profiles for all DCR-VMAT cases are presented in Figure 6.
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Figure 5. DCR-VMAT coronal and sagittal radiochromic film results for all cases.
Gamma analysis results using 3% and 3 mm criteria with no dose threshold are shown
for each measurement orientation. FilmQA Pro results are displayed as a product of
the gamma result and the dose deviation criterion, meaning 3% represents a γ value of
1. Isodose comparisons are shown for each measurement orientation, with thick lines
indicating the planned isodoses.
Dosimetric accuracy of DCR-VMAT for brain tumours 12
C
A
S
E
 1
C
A
S
E
 2
C
A
S
E
 3
C
A
S
E
 4
C
A
S
E
 5
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
Plan dose
Measured dose
Coronal film, lateral profile
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
Sagittal film, caudocranial profile
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Distance (cm)
A
b
s
o
lu
te
 d
o
s
e
 (
G
y
)
Figure 6. DCR-VMAT dose profiles for the sagittal and coronal film measurements
for all cases. Phantom orientations are shown for coronal film, point dose chamber,
and sagittal film measurements.
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Table 6. Root-mean-square error of gantry rotation for VMAT and DCR-VMAT and
couch rotation for DCR-VMAT.
Gantry rotation (◦) Couch rotation (◦)
Case VMAT DCR-VMAT DCR-VMAT
1 0.051 0.059 0.102
2 0.057 0.056 0.091
3 0.055 0.057 0.094
4 0.054 0.058 0.086
5 0.067 0.051 0.086
3.4. Linac log file analysis
Linac log file analysis showed similar gantry rotation RMSE for coplanar VMAT (median
0.055◦, range 0.051–0.067◦) and DCR-VMAT (median 0.057◦, range 0.051–0.059◦).
Couch rotation RMSE for DCR-VMAT was 0.091◦ (0.086–0.102◦). Full results are
presented in Table 6. Maximum couch rotation error for all VMAT cases was 0.002◦.
RMSE for individual MLC leaves are presented in Figure 7. Although all MLC errors
were small, statistically significant (p< 0.001) strong correlations were found between
RMSE and the total recorded leaf motion calculated from delivered log files. Spearman
coefficients were 0.82 and 0.88 for coplanar VMAT (leaf banks A and B, respectively)
and 0.83 for DCR-VMAT (both leaf banks).
3.5. Linac log file dose reconstruction
DCR-VMAT log file dose reconstructions produced plans with a median of 1239
(range 1210–1314) records, compared with 180 (180–202) control points used during
treatment planning. For VMAT, log file dose reconstructions used 759 (626–1291)
records compared with 180 control points during treatment planning.
Gamma analysis maps comparing DCR-VMAT treatment plan dose and
reconstructed dose from delivered log files are shown in Figure 8. These evaluate the
effect of errors due to the different number of control points used to calculate the dose
and mechanical errors recorded in the log file. All comparisons reported 100% of voxels
within the body ROI passing a γ2G/2, however some case-specific differences were seen
in the gamma analysis maps. The expected dose reconstructions, which excluded the
effect of log file reported delivery errors, also reported 100% of voxels passing γ2G/2 when
compared to the plan dose. Absolute dose differences between delivered and expected
dose reconstructions were within 0.3 Gy for all cases.
As the version of CERR used could not perform gamma analysis with local dose
difference normalisation, or with distance criteria below half the voxel size, reanalysis
with stricter gamma criteria (e.g. γ2L/2 or γ1G/1) was not performed. However, analysis
using γ2G/2 criteria was sufficient to identify any significant differences resulting from
the finer positional sampling of the log file dose reconstructions for the clinical standard
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Figure 7. MLC root-mean-square errors for coplanar VMAT plans and DCR-VMAT
plans for all Cases for MLC leaf banks A and B (left and right, respectively). MLC
leaf banks A and B correspond to X2 and X1 in IEC 61217.
dose calculation resolution used.
4. Discussion
This paper describes the dosimetric accuracy of single arc DCR-VMAT for five primary
brain tumour cases. DCR-VMAT meets clinical standards of dosimetric accuracy, with
point dose measurements all within 2% and gamma analysis (γ3G/3) pass rates >90%
(most>95%) for coronal and sagittal radiochromic film measurements. There are several
possible sources of uncertainty in the point dose and film measurements, including any
discrepancies between the delineated chamber volume and the effective measurement
point in the phantom, any deviation of the actual solid water block densities from
the water density assigned in the TPS, errors in phantom positioning and alignment,
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and uncertainties in the film calibration or readout. We have attempted to minimize
these uncertainties in practice. However, Vera-Sa´nchez et al (2018) have calculated
the uncertainty in absolute dose measurement for triple-channel film dosimetry using
Epson 10000XL flatbed scanners to be 2–3% for the target doses measured in this study.
For doses close to the low dose threshold used in our analysis, they calculate that the
uncertainty increases to 10%.
The scope of this study is limited to conventionally fractionated primary brain
tumours to evaluate the feasibility of DCR-VMAT treatment delivery for a site where it
has demonstrated potential clinical benefit (Smyth et al 2016). Although primary brain
tumours may not require the extensive MLC modulation necessary for sites such as the
head and neck (Fix et al 2018), more complex trajectories can be used due to the larger
non-collisional space around the patient (Wilson et al 2017). Further investigation of
the plan quality and dosimetric accuracy for other sites that may benefit from DCR-
VMAT, including stereotactic indications in the brain and body, is warranted in a future
study.
A full dosimetric comparison of the two techniques used in this paper has been
presented in Smyth et al (2016) for a 15-patient cohort of primary brain tumours.
Relevant dose volume histogram parameters for PTV and OARs, integral dose,
conformity, homogeneity, and gradient indices are presented and analysed. DCR-VMAT
is shown to produce statistically significant differences in PTV homogeneity that are
judged to be clinically acceptable in light of significant OAR sparing over VMAT. The
cases presented here are a subset of that cohort and the plans produced differ from
Smyth et al (2016) only in the linac model used (TrueBeam vs Synergy (Elekta AB,
Stockholm, Sweden) with Agility MLC) and the method of target dose normalisation
in Pinnacle3 (not normalised vs normalised to PTV mean dose). In this work, vertex
segments of arc are permitted during trajectory optimization, which could result in an
undesirable volume of very low exit dose through the patient’s length. While some of
this low dose can be constrained during plan optimization, an alternative approach is to
explicitly exclude from trajectory optimization any beam orientations where the beam
would continue through the patient beyond the limits of their CT scan (Wild et al 2015).
These results are consistent with the data presented in the literature to date for
other techniques using dynamic couch rotation. Fahimian et al (2013) report a single
TMAT delivery for a prone partial breast treatment plan. The deviation of point dose
measurement from plan prediction is 2.4%, while the gamma analysis pass rate for γ3G/3
is 93%. In a follow-up paper, Liang et al (2015) also report results for a single delivery.
For that case, the deviation in measured point dose from plan prediction is 1.6% and the
gamma analysis pass rate for γ3G/3 is 90.2%. Wilson et al (2017) report the validation
of TVMAT is within 2.2%, and 96–100% of film pixels meet gamma criteria of γ2G/2
for the four plans under investigation. Manser et al (2018) investigate the dosimetric
accuracy of a manually defined DCR-VMAT trajectory for a prostate case and find
96% of diodes meet gamma criteria of γ2G/2 in comparison to a research Monte Carlo
dose calculation. Fix et al (2018) report 99.5% of radiochromic film pixels meet gamma
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criteria of γ2G/2 for a head and neck DCR-VMAT treatment plan that uses geometric
trajectory optimization and a Monte Carlo dose calculation. The results in our paper
use a commercial adaptive convolution superposition dose calculation algorithm and are
consistent with reports of coplanar VMAT in a national audit using a diode array (Clark
et al 2014). The median (range) passing rate for γ3G/3 is 98.8% (83.8–100%) for linac
and TPS combinations that do not share a common vendor (Type 2 combinations), as
is the case in this work.
Passing rates for γ3G/3 may be insensitive to clinically significant errors introduced
during treatment planning or TPS commissioning, particularly when using arrays, but
these risks can be mitigated by evaluating deviations in point doses and dose profiles
(Nelms et al 2013) as performed in our paper. Gamma analysis results can also
vary significantly between measurement devices and calculation software (Hussein et al
2017). Future work on DCR-VMAT should include a systematic investigation of gamma
analysis sensitivity to technique-specific error combinations (e.g. miscalibration of
machine parameters, such as couch rotation and MLC position, or patient misalignment)
for a range of clinical sites using multiple measurement devices.
A limitation of the measurements in this paper is that they do not use an
anthropomorphic phantom. However, other groups also report results in water
equivalent plastic (Fahimian et al 2013, Liang et al 2015, Wilson et al 2017, Fix et
al 2018). Using a cubic phantom, as in our study, may increase the chance of detecting
errors that have been caused by inaccurate MLC, gantry, and couch synchronization,
when compared to an anthropomorphic head phantom with more gradual changes
in contour. Another limitation is that the measurements in this work only measure
planar dose distributions. Although it is common to use detector arrays that may
also interpolate between multiple measurement planes and evaluate the full three-
dimensional dose distribution, the use of these devices generally requires a coplanar
delivery. Verification of DCR-VMAT plans must also include the contribution of
the dynamic couch motion, which rules out the use of gantry-mounted diode arrays.
Alternative volumetric measurement techniques, such as gel dosimetry, should be
explored in future work.
Log file reported errors that have been determined for DCR-VMAT are small and
have limited dosimetric effect. Wilson et al (2017) analyse log files for TVMAT deliveries
and report couch rotation RMSE of 0.041–0.051◦ and gantry rotation RMSE of 0.042–
0.050◦. The larger couch rotation error results in this paper could be due to differences
in inertia between the TVMAT and DCR-VMAT techniques. TVMAT rotates the
couch fully in one direction before sweeping back, while the optimized DCR-VMAT
trajectories that have been investigated in this paper allow either clockwise or anti-
clockwise rotations throughout (Figure 2). In a previous study, a simulated systematic
2◦ error in couch rotation for DCR-VMAT increases OAR dose by up to 10% (Smyth
et al 2013), although a misalignment of that size is unlikely based on log file analysis.
This work investigates log file reported errors, however Agnew et al (2014) and Neal et
al (2016) demonstrate that there can be discrepancies between the log file reported and
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physical positions of linac components that are not identified by log file analysis. Wilson
and Gete (2017) recommend validating the accuracy of log file records and suggest
techniques for couch rotation. Although not performed in our study, this validation
step would be crucial before using log file values for pre-treatment delivery quality
assurance in the absence of dosimetric measurements such as those presented here.
This paper is the first to report linac log file dose reconstruction for dynamic couch
rotation techniques. The large number of samples that has been used in reconstruction
gives a close approximation of dynamic dose calculation and demonstrates that couch
and gantry control point spacing of 2◦ models dynamic delivery on the treatment
machine to within 2% and 2 mm. The dosimetric effect of linac reported mechanical
errors, determined from the difference between delivered log file and expected log file
dose reconstructions, was within 0.3 Gy for all cases in this study. Similar investigations
for coplanar VMAT using Monte Carlo dose calculation find differences of approximately
2%, which is consistent with the results in this paper (Teke et al 2010, Boylan et al 2013).
An alternative to static approximation during dose calculation is to model dynamic
linac motion directly within Monte Carlo dose calculation (Manser et al 2018, Fix et al
2018), although this is not yet commercially available. Future work should investigate
the validity of dose calculation for larger control point spacing.
DCR-VMAT delivery is slower than VMAT, with median (range) delivery times
of 125 s (123–133 s) and 78 s (64–130 s), respectively. These differences are unlikely
to be clinically important, especially when considering other aspects of the patient
treatment such as pre-treatment verification imaging. Comparison with published data
is challenging due to the different techniques and dose prescriptions that have been
evaluated (Fahimian et al 2013, Wild et al 2015, Liang et al 2015, Wilson et al 2017,
Fix et al 2018). Wild et al (2015) estimate times based on machine constraints for three
intracranial plans, with results from 3.9 min to 6.9 min depending on the complexity
of the trajectory and patient geometry. Fix et al (2018) report an average increase
in beam on time of 20% for DCR-VMAT when compared with VMAT for five cases
across four different tumour sites. For the brain cases that have been investigated in
our study, the median increase in delivery time is 60.3% but range from a 5.4% decrease
to a 108% increase. However, in the worst case the absolute increase in delivery time of
DCR-VMAT over the corresponding VMAT plan is 69 s.
As with other delivery techniques, rigorous quality control testing of DCR-VMAT
with strict tolerances is necessary (Wilson and Gete 2017). As well as existing tests for
VMAT, additional tests to confirm accurate synchronous motion of linac gantry, couch,
and MLC are required. Proposed synchronicity tests for VMAT (Bedford et al 2015,
Mans et al 2016) and TMAT (Yu et al 2014) rely on the linac’s on-board imaging device
and therefore may not be feasible for DCR-VMAT due to the risk of collisions during
non-coplanar motion.
Although we have shown that DCR-VMAT can be delivered accurately for the
five cases studied, issues such as patient safety and comfort must be investigated
prior to clinical implementation. Rotating the patient during treatment could induce
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intrafractional motion, which may be mitigated using improved patient immobilization.
Dynamic couch motion and the potential for patient-gantry collisions could also affect
patient compliance. Performing a “Day Zero” simulation of the treatment with
the patient present may be a simple method of providing reassurance, assuming
technological issues have been resolved. Patient stability during dynamic couch motion
should be further investigated in future work.
5. Conclusion
Results from the five patient cases in this paper suggest that clinical implementation of
dynamic couch rotation during VMAT is feasible for primary brain tumours, provided
that issues around patient safety, motion, and compliance are resolved. DCR-VMAT
plans have been delivered to within a clinically acceptable level of accuracy and with
a maximum delivery time of around 2 minutes using a commercial linear accelerator.
Future work should focus on investigating patient compliance and intrafractional motion,
and move towards implementing DCR-VMAT for primary brain tumours within a
clinical trial.
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